(Q33376259)
Statements
1 reference
A phase I clinical trial of low-dose interferon-alpha-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma (English)
1 reference
Robert J Amato
1 reference
Muhammad Khan
1 reference
14 August 2007
1 reference
1 reference
61
1 reference
1069-1073
1 reference
Identifiers
1 reference
1 reference